New Studies Will Explain How Isopathic Fungal Remedies Actually Work to Fight Disease
During the past few decades, a type of live blood analysis based on Prof. Dr. Guenther Enderlein’s work has been taught asserting that specific complex morphological structures in the blood were part of supposed microbial life cycles. Until very recently, this model of thinking had not been adapted to today’s scientific knowledge and tremendous technical options that allow researchers to investigate complex biological compositions, such as human blood, on a biochemical and immuno-histochemical basis.
Using highly sophisticated Proteom Research methods, European scientists have proven that, in terms of biochemical nature, specific darkfield bodies (known as symprotits) are actually degradation products of red blood cells. This important research conclusively refuted the previously held Enderlein theory that life cycles of bacteria start from a primitive protein, then develop into bacteria and, in some cases, finally culminate in a fungus.
A lecture presented by biochemist Ronald Ullmann at the BioResource seminar in Boulder, Colorado in March 2001 explained this new and essential research. A detailed account of the scientific work will be published and made available to practitioners within the next few months.
Gitte S. Jensen, Ph.D (Immunology) and Director of Holger Natural Immune Systems Inc. of Ashland, Oregon, supports these new investigations.
“Finally, rigorous scientific approaches are being applied to examining the exact nature of particles in the living blood,” pointed out Dr. Jensen, organizer of the International Symposia for Pleomorphic Microbes in Health and Disease. “I applaud the fact that BioResource is funding this type of research. It parallels work done in my laboratory, where data has been generated to confirm the involvement of true microbial life forms (i.e. containing nucleic acid material) in the blood from the chronically ill. However, we have also confirmed that many morphologies observed in the living blood are degradation products from unhealthy and stressed blood cells.”
“I have voiced my concerns for almost a decade about the risks of linking an alternative therapy with an alternative diagnostic tool, creating a closed loop of cause/effect relationships,” Dr. Jensen continued. “Separating the clinical validation of isopathic remedies from the chemical and biological identification of particles observed in the living blood should be saluted for its sound approach.”
If Enderlein’s theory is incorrect, why does isopathic therapy seem to have such a profound affect on the body? It was believed in some circles that isopathic fungal remedies worked by reversing or breaking down the upward development of microbial life cycles. Now that science has disproved this concept, new studies are being conducted to find out how isopathic remedies, such as SanPharma Mucor and Notatum, actually function in the body.
Updating Live Blood Microscopy
The Enderlein vocabulary used to describe microbial life cycles has met with strong resistance and open dispute from the worldwide medical community. This opposition is based on the fact that some of the blood particles described by Enderlein cannot be microbial in nature according to today’s definition of life and living particles.
In addition, the Enderlein vocabulary has led to conflict between darkfield practitioners and mainstream medicine. On the other hand, researchers who have successfully achieved recognition and wider acceptance of their live blood microscopy methods have adopted a vocabulary that reflects modern medical and scientific understanding of blood chemistry, cell biology and microbiology.
Many health care practitioners believe that live blood microscopy has value in the evaluation of patient health. Nevertheless, more clinical and scientific studies are required to put live blood analysis formally on the map of medical evaluation. Blood observations need to be evaluated scientifically, and the nature of the various blood morphologies determined biochemically and biologically.
As clearly demonstrated during the lecture at the BioResource seminar, many morphologies viewed in the darkfield are actually degradation products from red blood cells and platelets. These breakdown products relate to a patient’s state of health because illness will affect membrane lipid composition, membrane stability and cellular disintegration. For example, it is known scientifically that in patients who suffer from chronic illnesses, such as Chronic Fatigue Syndrome, the red blood cells can act as reservoirs for microbes hiding from the immune system. From inside the red cells, these microbes potentially can produce toxins and immuno-suppressing substances without being attacked by immune cells.
However, no microbial life cycles starting with a protein colloid and ending in the fungus Mucor racemosus or Aspergillus niger have been observed using modern scientific methods.
Renaming blood particles, applying the scientific process and obtaining molecular level research results – as well as clinical results in compliance with Good Clinical Practice standards – is a prerequisite to achieve recognition and validation for live blood evaluation as a valuable part of medicine.
BioResource is committed to bringing modern, scientific research to the field of isopathic therapy and biological medicine. Working with international scientists, our company is sponsoring molecular level research to examine old theories, and will fund clinical studies to show the efficacy of SanPharma biological remedies.
